Paraguay vs Sri Lanka: Death rate from cancer by sex
Paraguay
81.7 deaths per 100,000 people
in 2021
Sri Lanka
72.8 deaths per 100,000 people
in 2019
Paraguay rank
88th
Sri Lanka rank
91st
Death rate from cancer by sex over time
- Paraguay
- Sri Lanka
How they compare
Paraguay currently reports 81.7 deaths per 100,000 people against 72.8 deaths per 100,000 people in Sri Lanka, a difference of 8.9 deaths per 100,000 people.
That makes Paraguay's figure about 1.1 times Sri Lanka's.
Across all 16 years both countries report, Paraguay has been ahead every year.
Paraguay ranks 88th and Sri Lanka ranks 91st of 111 countries.
Paraguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Paraguay | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.06 deaths per 100,000 people | 59.78 deaths per 100,000 people | 26.27 deaths per 100,000 people | Paraguay |
| 2010s | 87.65 deaths per 100,000 people | 71.82 deaths per 100,000 people | 15.83 deaths per 100,000 people | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer by sex, Paraguay or Sri Lanka?
- Paraguay, at 81.7 deaths per 100,000 people against 72.8 deaths per 100,000 people in Sri Lanka as of 2021.
- What is the difference in death rate from cancer by sex between Paraguay and Sri Lanka?
- 8.9 deaths per 100,000 people, with Paraguay ahead.
- How many years of comparable data are there for Paraguay and Sri Lanka?
- 16 years are reported by both, from 2000 to 2019.
- How do Paraguay and Sri Lanka rank globally for death rate from cancer by sex?
- Paraguay ranks 88th and Sri Lanka ranks 91st of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) β with minor processing by Our World in Data, published as Death rate from cancer by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms in males in those aged all ages per 100,000 people.